HEALTH

Report: J&J pulls out of the race for Pfizer’s consumer business

BY Michael Johnsen

Johnson & Johnson is officially out of the running for Pfizer’s Consumer business, Reuters reported Thursday.

“While we would normally not comment on market speculation or rumors, in this instance we refute assertions that we are in negotiation for Pfizer’s consumer business,” J&J’s vice president of media relations Ernie Knewitz told Reuters.

That leaves GSK Consumer and RB in the running for the business. Pfizer is accepting bids on its business through Feb. 1 and is hoping to clear at least $20 billion in the sale, Reuters reported.

Drug Store News provided a look at who may or may not be interested in a Pfizer consumer business in Ocotober.

Pfizer fields several leading OTC brands across many of the more significant non-prescription categories. The company boasted almost $600 million in annual sales across U.S. total multi-outlets through its internal analgesic franchise (Advil and Advil PM) for the 52 weeks ended June 11, 2017, according to IRI. The proton pump inhibitor Nexium 24HR generated another $300 million and its vitamin lineup, featuring Centrum, pulled in more than $280 million.

According to Kline Group, based on 2016 sales Bayer holds an 8.2% market share of the overall OTC busines, with Johnson & Johnson following at 7.5% and GlaxoSmithKline Consumer Healthcare at 6.5%. Pfizer stands at No. 4 on that list with a 6.2% market share, followed by Procter & Gamble (4.5%), Sanofi (4.4%), Reckitt Benckiser (4%), Prestige Brands (1.9%), Church & Dwight (1.2%) and Carlyle Group (1%).

The marketshare figures are attributable to Kline & Company’s latest “Nonprescription Drugs USA” study.

For the full Reuters story, click here.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Walgreens Flu Index: Flu incidence snakes north from Texas

BY Michael Johnsen

Oklahoma, Montana and Iowa topped the list for flu activity gains as flu incidence appears to snake north from Texas, according to this week’s Walgreens Flu Index, the Deerfield, Ill.-based retailer announced Wednesday. Though Texas continued to dominate the map with the number of areas currently experiencing high levels of flu activity.

For the week ended Jan. 20, the top 10 markets presently experiencing flu activity were:

  1. El Paso, Texas (Las Cruces, N.M.);
  2. Corpus Christi, Texas;
  3. Waco-Temple-Bryan, Texas;
  4. Tyler-Longview (Lufkin & Nacogdoches), Texas;
  5. Harlingen-Weslaco-Brownsville-McAllen, Texas;
  6. Dallas-Ft. Worth, Texas;
  7. Beaumont-Port Arthur, Texas;
  8. Knoxville, Tenn.;
  9. Ft. Smith-Fayetteville-Springdale-Rogers, Ark.; and
  10. Cedar Rapids-Waterloo-Iowa City & Dubuque, Iowa.

The top 10 designated market areas by flu activity gains were:

  1. Oklahoma City;
  2. Cedar Rapids-Waterloo-Iowa City & Dubuque, Iowa;
  3. Lincoln & Hastings-Kearney, Neb.;
  4. Tulsa, Okla.;
  5. Chattanooga, Tenn.;
  6. La Crosse-Eau Claire, Wis.;
  7. Springfield, Mont.;
  8. Knoxville, Tenn.;
  9. Harlingen-Weslaco-Brownsville-McAllen, Texas; and
  10. Ft. Smith-Fayetteville-Springdale-Rogers, Ark.

The Walgreens Flu Index is a weekly report developed to provide state- and market-specific information regarding flu activity, and ranks those states and markets experiencing the highest incidences of influenza across the country. The Index provides insight by showing which cities or metropolitan areas are experiencing the most incidences of influenza each week based on Index methodology. The data does not measure actual levels or severity of flu activity.

The Index is compiled using weekly retail prescription data for antiviral medications used to treat influenza across Walgreens and Duane Reade locations nationwide, including Walgreens locations in Puerto Rico. The data is analyzed at state and geographic market levels to measure absolute impact and incremental change of antiviral medications on a per store average basis, and does not include markets in which Walgreens has fewer than 10 retail locations.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Latest SlimFast diet aid success to share all during FB Live event

BY Michael Johnsen

SlimFast on Tuesday named its new Weight Loss Transformation Coordinator, Chelsea C., who lost 168 lbs and is keeping it off with The SlimFast diet aid plan. “The Chance to work for SlimFast has changed my life. I get the opportunity to motivate people with my own story and in turn they inspire me,” Chelsea said.

Chelsea, who struggled with weight most of her life, decided to commit herself to losing the weight for good by incorporating SlimFast shake and snack diet aids into her daily routine while practicing portion control with the foods she loved. She now provides guidance and support for those beginning their weight loss journey on Palm Beach Gardens, Fla.- based company’s SlimFast Plan.

Her story will be featured in the Jan. 20, 2018 issues of Star, Us Weekly and Radar magazine, along with a SlimFast social media takeover that will include tips, tricks and recipes that helped Chelsea achieve her weight loss goal. Catch Chelsea, along with Registered Dietitian consultant Maryann Walsh, on Jan. 24 at 1 p.m. ET for a Facebook Live event featuring a Q&A session and Chelsea’s exclusive birthday cake smoothie recipe. “Chelsea’s weight loss journey and her ability to positively influence others by sharing her experience is such an amazing asset to the SlimFast community,” Walsh said.

Exclusive access to Chelsea and others who have been successful on The SlimFast Plan is available by joining SlimFast Together, a private Facebook Group that offers helpful tips, tricks and advice from fellow members.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?